Skip to main content

Author: Customer Service

OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans

LONDON and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced the filing of its Annual Report on Form 20-F for the fiscal year ended March 31, 2026, with the U.S. Securities and Exchange Commission (SEC). The report is available on the SEC’s website and the Company’s investor relations page. In conjunction with the filing, the Company provided a positive corporate update on its financial strength and clinical momentum. “We are pleased to announce the filing of our annual report, which reflects substantial progress across our operations,” said Keeren Shah, Chief Financial Officer of OKYO Pharma. “During the year we raised...

Continue reading

Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting

NASHVILLE, Tenn., July 20, 2026 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the presentation of three studies supporting IHEEZO® (chloroprocaine HCl ophthalmic gel 3%), a broadly labeled low viscosity ocular anesthetic gel, and BYOOVIZ® (ranibizumab-nuna)i, an FDA-approved biosimilar referencing LUCENTISii (ranibizumab) at the American Society of Retina Specialists (ASRS) 2026 Annual Meeting. Collectively, the presentations expand the growing body of clinical and real-world evidence supporting Harrow’s retina portfolio and reinforce Harrow’s commitment to generating quality evidence that strengthens physician confidence, improves patient experience, and supports long-term product adoption and innovation. “ASRS is one of the premier...

Continue reading

USA Rare Earth Announces Leadership Transition

Barbara Humpton to retire and Thras Moraitis to become CEO, both effective October 1, 2026 Michael Blitzer elected Executive Chairman, effective immediately STILLWATER, Okla., July 20, 2026 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (“USAR”, “USA Rare Earth”, or the “Company”), announced today that Barbara Humpton will retire as Chief Executive Officer and Board Director on October 1, 2026. USAR’s Board of Directors has named Thras Moraitis, current CEO of the Serra Verde Group (“Serra Verde”) and a highly experienced operator in the rare earths industry, as Ms. Humpton’s successor. Mr. Moraitis will assume the CEO role on October 1, 2026, following the anticipated completion of USAR’s combination with Serra Verde by the end of August. During the interim period, Mr. Moraitis will continue to oversee the combined company’s...

Continue reading

Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World’s Premier Scientific Meetings in Oncology

Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced disease; patient who received Namodenoson as second-line therapy remains alive more than 18 months Ramat Gan, Israel, July 20, 2026 (GLOBE NEWSWIRE) —  Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced that an abstract highlighting positive results from its Phase 2a study of Namodenoson in patients with advanced pancreatic ductal adenocarcinoma (PDAC), has been accepted for poster presentation at the European Society for Medical Oncology (ESMO) Congress 2026. The accepted abstract, entitled “Durable Disease Stabilization with Namodenoson in Advanced Pancreatic...

Continue reading

Alternative Ballistics Corporation (OTCQB: ALBC) Announces PT Panglima Pandawa Sakti as First International Online Marketplace for The Home Defense™

Agreement marks the Company’s first direct-to-consumer e-commerce channel outside the United States, advancing the Company’s global commercialization strategy Las Vegas, NV, July 20, 2026 (GLOBE NEWSWIRE) — Alternative Ballistics Corporation (OTCQB: ALBC) (“ALBC” or the “Company”), developer of innovative less-lethal technologies, today announced that PT Panglima Pandawa Sakti, an Indonesian defense solutions company, will lead the way in becoming the first international online marketplace to offer The Home Defense™ to qualified customers within its authorized market. The Home Defense™ was developed to provide responsible gun owners with a less-lethal-first option that may allow them to stop or deter a threat before resorting to deadly force. Using Alternative Ballistics’ patented...

Continue reading

Orezone Resumes Operations at Casa Berardi; Reaffirms 2026 Production Guidance

VANCOUVER, British Columbia, July 20, 2026 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE | ASX: ORE | OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to announce that operations resumed at its Casa Berardi mine in Quebec on the evening of July 17, following the voluntary suspension of operations announced on July 14 due to nearby wildfire activity. During the temporary suspension, a skeleton workforce remained on site to preserve the operation while advancing planned maintenance activities originally scheduled for later in the year. As a result, the Company expects to benefit from reduced planned maintenance downtime over the balance of 2026. The Company reaffirms its 2026 production guidance of 62,000 to 67,000 ounces from Casa Berardi. Orezone would like to thank SOPFEU (Société de protection des forêts contre le...

Continue reading

Kraken Robotics Announces $35 Million in New Orders and Business Update

Year-to-Date the Company has Announced $327 Million in Combined Product Orders TORONTO, July 20, 2026 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (“Kraken” or the “Company”) (TSX-V: PNG, OTCQB: KRKNF) is pleased to announce continued momentum with $35 million in new product orders from customers in maritime defense, offshore energy, and ocean science. By technology solution, these orders are across navigation and positioning systems, multi-aperture sonar, positioning, and monitoring systems from Covelya, as well as Synthetic Aperture Sonar (SAS) from Kraken. “Our product portfolio forms the backbone of a wide range of platforms used across both defence and commercial applications and we expect it to represent over 75% of consolidated revenue in 2026,” said Greg Reid, CEO of Kraken Robotics. “These include crewed platforms such as ships...

Continue reading

Azimut Announces $7 Million Private Placement Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LONGUEUIL, Quebec, July 20, 2026 (GLOBE NEWSWIRE) — Azimut Exploration Inc. (TSXV: AZM) (OTCQX: AZMTF) (“Azimut” or the “Company”) announces it intends to proceed with a non-brokered private placement (the “Offering”) for total proceeds of up to $7,000,000, consisting of 6,038,647 common shares of the Company that qualify as “flow-through shares” (within the meaning of subsection 66(15) of the Income Tax Act (Canada)) (the “FT Shares”) at a price of $0.828 per FT Share, and 3,333,333 common shares of the Company (the “Hard Dollar Shares”) at a price of $0.60 per Hard Dollar Share. The Company will use an amount equal to the gross proceeds received from the sale of the FT Shares, pursuant to the provisions in the Income Tax Act (Canada),...

Continue reading

Brookfield and CPP Investments to Acquire LXP Industrial Trust in $5.2 Billion All-Cash Transaction

LXP Industrial Trust shareholders to receive $61.20 per share in cash Purchase price represents a 12.3% premium to the 30-day VWAP and a 19.8% premium to the 90-day VWAP NEW YORK and TORONTO and WEST PALM BEACH, Fla., July 20, 2026 (GLOBE NEWSWIRE) — Brookfield Asset Management (NYSE: BAM, TSX: BAM) (“Brookfield”), together with Canada Pension Plan Investment Board (“CPP Investments”), and LXP Industrial Trust (NYSE: LXP) (“LXP” or the “Company”), today announced that they have entered into a definitive merger agreement under which Brookfield and CPP Investments (collectively, “Buyer”) will acquire LXP in an all-cash transaction valued at approximately $5.2 billion, including net debt and preferred equity. LXP owns one of the largest portfolios of modern warehouse and logistics facilities in the United States, comprising approximately...

Continue reading

GE Aerospace Partners with NASA, BETA Technologies, and Boeing on World’s First High-Altitude Hybrid Electric Flight

GE Aerospace EPFDGE Aerospace EPFDFARNBOROUGH, England, July 20, 2026 (GLOBE NEWSWIRE) —Hybrid electric system enabled aircraft to reach more than 30,000 feet First public demonstration takes place at Farnborough International AirshowFARNBOROUGH, England – July 20, 2026 – GE Aerospace (NYSE: GE) announced today at the Farnborough International Airshow an industry first to advance the future of flight, demonstrating the viability of more electric aircraft engine systems for aviation. In collaboration with NASA, BETA Technologies, Inc. (NYSE: BETA) (“BETA”) and Boeing, GE Aerospace conducted the first hybrid electric flight above 30,000 feet, reaching the same altitude levels of passenger commercial aircraft. During tests, the team’s single longest flight in hybrid electric operation was more than two hours.  The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.